MarketsandMarkets

Tissue Diagnostics Market Worth $3,924.01 Million by 2018 – Prominent Players in This Market - Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.) & Thermo Fisher

Tissue Diagnostics Market report categories the Global market by Technology (Digital pathology & Workflow, Immunohistochemistry, in Situ Hybridization, Special Staining), Disease (Breast Cancer, Lymphoma, Gastric Cancer, Non Small Cell Lung Cancer , Prostate Cancer and Others), Product, End-Users & by Region (The Americas, Europe, BRIC, Japan & RoW)

 

Dallas, TX -- (SBWIRE) -- 12/11/2014 -- According to a new market research report "Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018"

The global tissue diagnostics market is expected to grow at a CAGR of close to 6.97% between 2013 and 2018, to reach $3,924.01 million by 2018.

For More Details
http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1063949

Tissue diagnostics are an important set of techniques, primarily used for the diagnosis, monitoring and management of cancer. The market includes instruments, reagents and kits used to determine the stage, prognosis, and treatment course of the disease. Increasing global incidences of cancer, the adoption of tissue diagnostic products as companion diagnostics in personalized medicine for cancer and the rapidly aging global population are expected to be the three most important growth drivers for the global market.

The report segments this market by technology, disease, product, end user and geography. The IHC technology segment commanded the largest share of the global market and is also poised to grow at the highest CAGR between 2013 and 2018, due to the increasing use of IHC products as companion diagnostics in personalized medicine for cancer.

Due to its rapidly increasing incidence, the breast cancer disease segment commanded the largest share of the global market. Breast cancer is the most common form of cancer in women and is highly amenable for tissue diagnostics. It is also poised to grow at the highest CAGR between 2013 and 2018.
Table of Content

Introduction
Executive Summary
Premium Insights
Market Overview
Global Tissue Diagnostics Market, By Technology
Global Tissue Diagnostics Market, By Disease
Global Tissue Diagnostics Market, By Product
Global Tissue Diagnostics Market, By End User
Geographic Analysis
Competitive Landscape
Company Profiles (Business Overview, Products & Services, Key Strategy, & Recent Developments)

Speak with Research Analyst
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=1063949

Tissue diagnostics finds primary application for diagnosis of cancer. As such, the hospital end-user segment commanded the largest share of the global market, while the research laboratories end-user segment is poised to grow at the highest CAGR between 2013 and 2018. The use of tissue diagnostic products for research purposes is expected to remain low.

About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: 888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog
http://mnmblog.org/market-research/healthcare/medical-devices